Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 241-250 of 409 for center for individualized medicine

Edit search filters
  1. Primary Hyperoxaluria Mutation Genotyping

    Rochester, MN

  2. A Study of OX40L As a Functional Biomarker for Liver Fibrosis

    Scottsdale/Phoenix, AZ

  3. A Study To Evaluate The Development Of Patient Derived Xenografts In Patients With Breast Cancer

    Rochester, MN

  4. North American Mitochondrial Disease Consortium Patient Registry and Biorepository (NAMDC)

    Rochester, MN

  5. A Study Evalauting Genetic Information in Oocyte Donor Selection

    Rochester, MN

  6. Epilepsy Genetics Initiative (EGI)

    Rochester, MN

  7. Plasma Proneurotensin As A Predictive Biomarker For Breast Cancer In Genetically Predisposed Patients

    Jacksonville, FL, Rochester, MN

  8. Dominantly Inherited Alzheimer Network (DIAN)

    Jacksonville, FL

  9. A Study to Collect Information about Biomarkers (Lab Test Results) that May Help to Predict Which People with Calf Vein Clots May be at Higher or Lower Risk of Having the Clot Grow or Progress

    Rochester, MN

  10. Comparison of Pharmacogenomic Testing Results Across Companies

    Rochester, MN

.

Mayo Clinic Footer